In contrast, we could identify other mitochondrial genes involved in C1 metabolism that are strongly associated with the prognosis in cancer patients, which we believe have the potential to be more efficient anticancer targets than DHFR, which is the anticancer target of folate metabolism. Here, DHFR is linked to cancer.